Other languages ALK-Abelló A/S

Equities

ALK B

DK0061802139

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:44 2024-05-03 EDT			5-day change	1st Jan Change
148.8 ^DKK	+13.59%		+14.46%	+47.04%

05-03	Transcript : ALK-Abelló A/S, Q1 2024 Earnings Call, May 03, 2024
05-02	ALK-Abelló A/S Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aggiornamento sui forti movimenti della giornata: Banks, Genmab, Daimler Truck ... risultati riassunti qui!	05-03
Actualización de las fuertes variaciones del día: Bancos, Genmab, Daimler Truck ... ¡resultados resumidos aquí!	05-03
Les actions en mouvement : Les banques, JCDecaux, Bonduelle ... les publications de résultats résumées ici !	05-03
ALK-Abelló A/S Reports Earnings Results for the First Quarter Ended March 31, 2024	05-02
ALK-Abelló A/S Updates Revenue Guidance for the Year 2024	05-02
ALK-Abelló A/S Provides Earnings Guidance for the Year 2024	05-02
ALK-Abelló A/S: nessuna allergia in vista	03-22
EN DIRECTO DESDE LOS MERCADOS: Inditex, Aena, Acciona Energía, Iberdrola, Rovi, Adidas, Tod's, Volkswagen, CME Group...	03-13
ALK-Abelló A/S: Sin alergia en el horizonte	03-12
Neuzugänge im EU-Portfolio von MarketScreener	03-05
Nuovo acquisto nel portafoglio Europa	03-05
Nieuwe aankopen voor de Europese portefeuille	03-05
Nieuwe aankopen voor de Europese portefeuille	03-05
Nuevas compras en la cartera Inversor Europa	03-04
Nouveaux achats dans le portefeuille Investisseur Europe PEA	03-04
ALK-Abelló A/S Reports Earnings Results for the Full Year Ended December 31, 2023	02-08
Alk-Abelló A/S Provides Revenue Guidance for the Year of 2024	02-08
ALK-Abelló’s Carbon Reduction Targets Gets Validation from Science-Based Targets Initiative	02-05
Alk's European Registration Application for House Dust Mite Slit-Tablet in Young Children Accepts for Review	01-25
ALK-Abelló’s Peanut Allergy Treatment Shows Safety, Tolerability in First Part of Early-stage Trial	01-18

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ALK-Abelló A/S : No allergy on the horizon

March 12, 2024 at 10:20 am